Immix Biopharma, Inc. IMMX Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Immix Biopharma, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s earnings yield?
- Immix Biopharma, Inc. (IMMX) reported earnings yield of -7.2% in Q1 2026.
- How has Immix Biopharma, Inc.'s earnings yield changed year-over-year?
- Immix Biopharma, Inc.'s earnings yield increased by 83.9% year-over-year, from -44.9% to -7.2%.
- What is the long-term trend for Immix Biopharma, Inc.'s earnings yield?
- Over 4 years (2021 to 2025), Immix Biopharma, Inc.'s earnings yield has grown at a -31.9% compound annual growth rate (CAGR), from -49.5% to -10.7%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.